Clinical studies with podophyllum compounds SPI-77 (NSC-72274) and SPG-827 (NSC-42076).
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011035:Podophyllum / Q000009:adverse effects*
D000970:Antineoplastic Agents